Zynext Ventures USA LLC today announced its investment in Feldan Therapeutics (Feldan), a Canada-based early clinical-stage ...

A research team from the Institute of Statistical Mathematics and Panasonic Holdings Corporation has developed a machine ...

In a major step toward more reliable AI-assisted molecular design, researchers from National Taiwan University have ...

DiaGen Ai Inc. Announces its Selection as a Top 100 Canadian Tech Company VANCOUVER, BC, CANADA, April 11, 2025 /EINPresswire / -- DiaGen Ai I ...

Longhorn Vaccines and Diagnostics, a One Health company developing treatments and diagnostic tools for global public health and zoonosis concerns, will present new data from universal influenza ...

Abstract: Combining artificial intelligence (AI) technology with antenna optimization has long been a research direction with significant potential. However, most contributions in this area have ...

For three weeks last May, employees of the AI giant Nvidia and Recursion Pharmaceuticals slept on the floor of a data center in Salt Lake City. They were there to build a machine that Recursion, a ...

Interesting research titled ‘Strategies for the design of biomimetic cell-penetrating peptides using AI-driven in silico tools for drug delivery’ has been published. DCU’s Prof Nicholas Dunne ...

The company is building what it describes as an AI drug design engine. The software reduces the amount of manual work involved in developing new medicines and thereby speeds up the process.

AI and the pharmaceutical market are an ideal match. Drug discovery and development companies are burdened with intense competitive and financial pressure to shorten timelines and accelerate ...